Tumor development and progression of experimental skin squamous cell carcinoma (SCC) induced by chemical carcinogens and promoters are a consequence of genetic lesions including not only abnormalities of known oncogenes and tumor suppressor genes but also the overexpression of cell cycle related genes (CCRG) such as cyclin D1. The fact that the principal investigator is ahead of everyone else in this field guarantees that definitive progress will be made during the proposed funding period. The present proposal relates to the study of a group of human SCC's of the oral cavity that have a strong etiological linkage with alcohol and tobacco consumption and also harbor similar abnormalities in cyclin D1. The hypothesis is that increased expression of multiple G1 cyclins and their respective Cdk's can be used as markers of poor prognosis in human head and neck SCC's, and that this occurs in most cases without gene amplification via either increased rates of transcription, increased message stability, or post-translational mechanisms such as increased protein half-life. Experiments are designed to: a) detect changes in G1/S cyclins, and their respective Cdk's in oral cancer and its precursors; b) utilize an extensive epidemiological data bank to which the principal investigator has access to evaluate the role of CCRG abnormalities in oral cancer as a function of tobacco-alcohol consumption as well as dietary habits and family-clinical history; c) confirm in a large series of human lesions that CCRG overexpression could be used as a marker of tumor progression and poor prognosis; d) determine which component of the invasive/metastatic cascade is implicated in tumor progression; and e) investigate in selected SCC cell lines which CCRGs are most significant in inducing enhancement of the malignant phenotype, and which are the basic mechanisms behind the overexpression of CCRGs in SCC cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA071539-01A1
Application #
2010066
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1997-05-15
Project End
2002-02-28
Budget Start
1997-05-15
Budget End
1998-02-28
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Mahloogi, Haleh; Gonzalez-Guerrico, Anatilde M; Lopez De Cicco, Ricardo et al. (2003) Overexpression of the calcium sensor visinin-like protein-1 leads to a cAMP-mediated decrease of in vivo and in vitro growth and invasiveness of squamous cell carcinoma cells. Cancer Res 63:4997-5004
Mercapide, Javier; Zhang, Shi Yu; Fan, Xing et al. (2002) CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast. Mol Carcinog 35:6-12
Liu, Shao Chen; Bassi, Daniel E; Zhang, Shi Yu et al. (2002) Overexpression of cyclin D2 is associated with increased in vivo invasiveness of human squamous carcinoma cells. Mol Carcinog 34:131-9
Salter, E R; Tichansky, D; Furth, E E et al. (2001) Tumor-associated antigen expression and growth requirements predict tumorigenesis in squamous cell carcinoma. In Vitro Cell Dev Biol Anim 37:530-5
Liu, S C; Zhang, S Y; Babb, J S et al. (2001) Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 10:455-9
Liu, S C; Klein-Szanto, A J (2000) Markers of proliferation in normal and leukoplakic oral epithelia. Oral Oncol 36:145-51
Zhang, S Y; Liu, S C; Johnson, D G et al. (2000) E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. Cancer Res 60:5972-6
Zhang, S Y; Liu, S C; Al-Saleem, L F et al. (2000) E2F-1: a proliferative marker of breast neoplasia. Cancer Epidemiol Biomarkers Prev 9:395-401
Liu, S C; Hu, Y; Sauter, E R et al. (1999) Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa. Anal Quant Cytol Histol 21:166-73
Liu, S C; Sauter, E R; Clapper, M L et al. (1998) Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity. Cancer Epidemiol Biomarkers Prev 7:597-603